HER2 drugs for Breast Cancer

4 tracked HER2 drugs in the Breast Cancer race. The class explanation lives on the HER2 page; the full indication pipeline across every mechanism is on the Breast Cancer page.

3 approved / phase 41 Phase 3

Head-to-head evidence: Trastuzumab Deruxtecan vs Trastuzumab rezetecan · Trastuzumab Deruxtecan vs Tucatinib · margetuximab vs Trastuzumab Deruxtecan · Trastuzumab rezetecan vs Tucatinib · margetuximab vs Tucatinib

The roster

← all HER2 drugs